Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

Chafika Mazouni; Florentia Peintinger; Shu Wan-Kau; Fabrice Andre; Ana M Gonzalez-Angulo; W Fraser Symmans; Funda Meric-Bernstam; Vicente Valero; Gabriel N Hortobagyi; Lajos Pusztai

doi:10.1200/JCO.2006.08.2271

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

Chafika Mazouni, Florentia Peintinger (Co-author), Shu Wan-Kau, Fabrice Andre, Ana M Gonzalez-Angulo, W Fraser Symmans, Funda Meric-Bernstam, Vicente Valero, Gabriel N Hortobagyi, Lajos Pusztai

Research output: Contribution to journal › Original Article (Journal) › peer-review

216 Citations (Web of Science)

Original language	English
Pages (from-to)	2650-2655
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	25
Issue number	19
DOIs	https://doi.org/10.1200/JCO.2006.08.2271
Publication status	Published - 2007

Keywords

PATHOLOGICAL COMPLETE RESPONSE
GENE-EXPRESSION PROFILES
SURGICAL ADJUVANT BREAST
PROGNOSTIC-SIGNIFICANCE
INDUCTION CHEMOTHERAPY
DOXORUBICIN
TUMOR
WOMEN
CYCLOPHOSPHAMIDE
PACLITAXEL

Access to Document

10.1200/JCO.2006.08.2271

Cite this

Mazouni, C., Peintinger, F., Wan-Kau, S., Andre, F., Gonzalez-Angulo, A. M., Symmans, W. F., Meric-Bernstam, F., Valero, V., Hortobagyi, G. N., & Pusztai, L. (2007). Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. JOURNAL OF CLINICAL ONCOLOGY , 25(19), 2650-2655. https://doi.org/10.1200/JCO.2006.08.2271

Mazouni, Chafika ; Peintinger, Florentia ; Wan-Kau, Shu et al. / Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. In: JOURNAL OF CLINICAL ONCOLOGY 2007 ; Vol. 25, No. 19. pp. 2650-2655.

@article{d496771aef5d4ae3a7f385ffb08d6635,

title = "Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.",

keywords = "PATHOLOGICAL COMPLETE RESPONSE, GENE-EXPRESSION PROFILES, SURGICAL ADJUVANT BREAST, PROGNOSTIC-SIGNIFICANCE, INDUCTION CHEMOTHERAPY, DOXORUBICIN, TUMOR, WOMEN, CYCLOPHOSPHAMIDE, PACLITAXEL",

author = "Chafika Mazouni and Florentia Peintinger and Shu Wan-Kau and Fabrice Andre and Gonzalez-Angulo, {Ana M} and Symmans, {W Fraser} and Funda Meric-Bernstam and Vicente Valero and Hortobagyi, {Gabriel N} and Lajos Pusztai",

year = "2007",

doi = "10.1200/JCO.2006.08.2271",

language = "English",

volume = "25",

pages = "2650--2655",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "19",

}

Mazouni, C, Peintinger, F, Wan-Kau, S, Andre, F, Gonzalez-Angulo, AM, Symmans, WF, Meric-Bernstam, F, Valero, V, Hortobagyi, GN & Pusztai, L 2007, 'Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.', JOURNAL OF CLINICAL ONCOLOGY , vol. 25, no. 19, pp. 2650-2655. https://doi.org/10.1200/JCO.2006.08.2271

Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. / Mazouni, Chafika; Peintinger, Florentia (Co-author); Wan-Kau, Shu et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 25, No. 19, 2007, p. 2650-2655.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.

AU - Mazouni, Chafika

AU - Peintinger, Florentia

AU - Wan-Kau, Shu

AU - Andre, Fabrice

AU - Gonzalez-Angulo, Ana M

AU - Symmans, W Fraser

AU - Meric-Bernstam, Funda

AU - Valero, Vicente

AU - Hortobagyi, Gabriel N

AU - Pusztai, Lajos

PY - 2007

Y1 - 2007

KW - PATHOLOGICAL COMPLETE RESPONSE

KW - GENE-EXPRESSION PROFILES

KW - SURGICAL ADJUVANT BREAST

KW - PROGNOSTIC-SIGNIFICANCE

KW - INDUCTION CHEMOTHERAPY

KW - DOXORUBICIN

KW - TUMOR

KW - WOMEN

KW - CYCLOPHOSPHAMIDE

KW - PACLITAXEL

U2 - 10.1200/JCO.2006.08.2271

DO - 10.1200/JCO.2006.08.2271

M3 - Original Article (Journal)

C2 - 17602071

SN - 0732-183X

VL - 25

SP - 2650

EP - 2655

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 19

ER -

Mazouni C, Peintinger F, Wan-Kau S, Andre F, Gonzalez-Angulo AM, Symmans WF et al. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome. JOURNAL OF CLINICAL ONCOLOGY . 2007;25(19):2650-2655. doi: 10.1200/JCO.2006.08.2271